BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Strong Proof-of-Concept Data from Phase 2 Trial of PDE10A Inhibitor (CPL’36), a Novel Once-Daily Treatment of Levodopa-Induced Dyskinesia in Parkinson’s Disease

  March 4, 2025

   · 

  8 min read
• Press Releases

  NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results

  March 4, 2025

   · 

  13 min read
• Press Releases

  Enlivex Therapeutics Announces Investor Webinar to Discuss Positive Interim Data from Phase I/II Allocetra™ Trial in Knee Osteoarthritis

  March 4, 2025

   · 

  4 min read
• Press Releases

  Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

  March 4, 2025

   · 

  18 min read
• Press Releases

  AMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDEND

  March 4, 2025

   · 

  7 min read
• Press Releases

  BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells

  March 4, 2025

   · 

  6 min read
• Press Releases

  Rigel Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

  March 4, 2025

   · 

  19 min read
• Press Releases

  Contineum Therapeutics Initiates Patient Dosing in Phase 1b Chronic Pain Trial of PIPE-791

  March 4, 2025

   · 

  5 min read
• Press Releases

  ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results

  March 4, 2025

   · 

  18 min read
• Press Releases

  Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025

  March 4, 2025

   · 

  9 min read